Millennium Health Appoints Scott Walton as Chief Executive Officer
SAN DIEGO, Calif. – October 26, 2021 – Millennium Health, a national leader in specialty medication monitoring and drug testing, today announced the appointment of Scott Walton as Chief Executive Officer (CEO) effective immediately.Read More
Millennium Health Study Published in Drug and Alcohol Dependence Highlights COVID-19, Seasonal and Regional Influences on Alcohol Consumption
SAN DIEGO, Calif. – October 5, 2021 – According to the Centers for Disease Control and Prevention (CDC), excessive alcohol use remains the leading cause of preventable death in the U.S., with over 95,000 deaths every year due to alcohol-related causes.1 Read More
Distinguished Psychologist and Addiction Specialist Joins Millennium Health Management Team
SAN DIEGO, Calif. – September 22, 2021 – Specialty medication monitoring and drug testing company, Millennium Health today announced leading pain and addiction expert, Steven D. Passik, PhD has joined its management team as VP, Scientific Affairs and Head of Clinical Data Programs. Dr. Passik will focus primarily on expanding work begun at Millennium Health to inform clinicians, policy makers and public health officials about the changing landscape of substance abuse to help facilitate a data driven approach to this enormous public health problem.
Millennium Health Publication in JAMA Network Open Highlights Drug Use Trends in Patients Treated with Buprenorphine for Opioid Use Disorder
SAN DIEGO, Calif. – September 14, 2021 – A JAMA Network Open study, led by Brendan Saloner, PhD, Associate Professor with Johns Hopkins Bloomberg School of Public Health, and co-authored by Millennium Health researchers, highlights the role of buprenorphine as a critically important medication for reducing harmful opioid use.
Columbia University and Millennium Health Join Forces to Combat Overdoses in New York
SAN DIEGO, Calif. – August 31, 2021 – Millennium Health, a leader in delivering clinical drug testing services to health care providers, has entered into an agreement with Columbia University to provide valuable, real-time drug use trends data through our Emerging Threat Intelligence (ETI) Program™ to aid their efforts with the HEALing Communities Study (HCS) in New York.
Millennium Health Announces Expansion of Oral Fluid Drug Test Menu
SAN DIEGO, Calif. – April 26, 2021 – Millennium Health is pleased to announce that it has expanded its oral fluid drug test (OFT) menu to include definitive testing via LC-MS/MS for additional drugs:
Millennium Health Signals Report™ Analyzes Drug Use Trends Amid the Pandemic
Latest Report Demonstrates National, Regional, and State-Specific Drug Use Patterns
SAN DIEGO, Calif. – February 24, 2021 – Reports of increased drug overdoses and drug overdose deaths during the COVID-19 pandemic are highlighting an increased need for innovative approaches to substance use disorder prevention and treatment.
Millennium Health Study Reveals Nationwide Increase in Urine Drug Test Positivity for Methamphetamine
SAN DIEGO, Calif. – January 5, 2021 – A study conducted by Millennium Health and published in the Journal of Addiction Medicine reveals a dangerous increase in definitive urine drug test positivity for methamphetamine alone and in combination with other substances.
Millennium Health Identifies National Fentanyl Analog Positivity Which May Increase Risk of Overdose Death
SAN DIEGO, Calif. – October 7, 2020 – A study conducted by Millennium Health and published in Drug and Alcohol Dependence highlights the role real-time urine drug test results can play in identifying dangerous drug abuse trends including fentanyl analog positivity nationwide.
JAMA Study Co-Authored by the U.S. Department of Health & Human Services (HHS) and Millennium Health Uncovers Significant Increase in Drug Use Amid COVID-19 Pandemic
SAN DIEGO, Calif. – September 23, 2020 – A study co-authored by the U.S. Department of Health & Human Services and Millennium Health published in JAMA highlights a national increase in urine drug test positivity rates during COVID-19 for fentanyl, methamphetamine, cocaine, and heroin.
Patient Billing
(877) 451-7337
Monday-Friday 6:00AM-4:00PM PT
Corporate Headquarters
(877) 451-3534
